Relypsa, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 11 of 11 Posts
Dow Jones Industrial Average Today Slumps After Weak Earnings, Lower Oil Prices
Article By: Garrett Baldwin Thursday, July 21, 2016 9:22 PM EDT
The Dow Jones Industrial Average today snapped a nine-session winning streak, slumping after weaker earnings, falling oil prices, and a short-term end to the global sugar high of falling interest rates and more stimulus.
In this article: CMG, DAL, GM, IOC, JOY, LUV, P, T, UAL, V, XOM, KMTUY, INTC, SBUX, OIL, USO, AAL, RLYP
Read
4 Takeover Stocks To Buy This Summer
Article By: Bret Jensen Sunday, June 5, 2016 10:39 AM EDT
Biotech has gone a real tear over the past three weeks after making several “false starts” over the past several months as it emerges from an immense bear market that began late in July of last year. This move feels more real than previous bounces.
In this article: ACAD, ARDX, BIIB, PTLA, RLYP Also: ANAC, XNPT, ABBV, CPXX, AGN, PFE, MDVN, MRK, SNY
Read
Mizuho Analyst Criticizes Valeant Pharmaceuticals Intl Inc And Relypsa Inc; Here’s Why
Article By: TipRanks Tuesday, May 31, 2016 11:48 PM EDT
As Valeant Pharmaceuticals Intl Inc continues to face legal battles on several fronts and Relypsa Inc struggles to ramp sales of its new drug, Irina Rivkind Koffler of Mizuho explains why she remains bearish on both companies.
In this article: VRX, RLYP
Read
E Relypsa Gains 8% On Competitor's FDA Rejection
Article By: Terry Chrisomalis Friday, May 27, 2016 7:56 PM EDT
Although the day's news regarding the hyperkalemia drug was good for Relypsa, AZN escaped the day relatively unscathed due to good news for two of its other drugs.
In this article: RLYP, AZN
Read
Biotech's Week Ahead: Relypsa, GW Pharmaceuticals, Regeneron And Exelixis
Article By: TipRanks Sunday, May 1, 2016 2:17 PM EDT
It’s an exciting week ahead for pharma companies Relypsa Inc, GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc and Exelixis, Inc., as analysts anticipate quarterly reports and sales updates on key drugs. Here is what to watch.
In this article: REGN, EXEL, GWPH, RLYP
Read
These 4 Stocks Will Lead The Biotech Rally In 2016
Article By: Bret Jensen Sunday, April 10, 2016 2:48 AM EDT
Their deeply oversold valuations represent amazing long-term entry points as each of these four stocks own products that are going to dominate their niches. Now is the time to buy as the biotech sector starts to rally.
In this article: ACAD, BDSI, DVAX, MACK, RLYP Also: AGN, PFE, IBB, VRX
Read
3 Undervalued Biotech Stocks With Upcoming Catalysts
Article By: Bret Jensen Tuesday, March 15, 2016 3:31 PM EDT
New drug approvals and the rollout of just-commercialized products will be the catalysts that send these undervalued stocks rallying: DVAX, ACAD and RLYP.
In this article: ACAD, DVAX, RLYP Also: AZN, GSK
Read
Is This The Bottom For Biotech?
Article By: Bret Jensen Tuesday, March 1, 2016 11:08 PM EDT
With the biotech sector behaving much better recently, it is time to look into if a bottom has formed and new investments in the market are warranted.
In this article: ESRX, GILD, ABBV, RLYP
Read
3 Post-Sell-Off Bargains To Buy In Biotech
Article By: Bret Jensen Tuesday, February 23, 2016 1:47 PM EDT
The biotech sector is offering valuations so cheap right now that in some cases you can buy shares in a company for less than the cash they have in the bank. Sentiment won’t stay this low forever.
In this article: SRNE, GILD, RLYP Also: ZSPH, AZN, CELG
Read
Top 3 Biotech Takeover Targets To Buy
Article By: Bret Jensen Saturday, January 2, 2016 4:47 PM EDT
I will bet that 2016 will bring a reversion to the mean and small cap equities will once again outperform their larger brethren. Here are several small cap selections that should do very well in 2016 should that indeed occur.
In this article: AGEN, ANIP, RLYP Also: MRK, VRX, INCY, TEVA, ZSPH, ADRO, AZN, GSK
Read
3 Stocks To Buy On The Verge Of Breakouts In 2016
Article By: Bret Jensen Tuesday, December 22, 2015 10:16 PM EDT
Give yourself a holiday gift by purchasing shares of these three stocks on the verge of big breakouts in 2016. Act now because these stocks won’t be so cheap once the market realizes their potential.
In this article: CLDT, SQBG, RLYP Also: AZN, MSO, ZSPH
Read
1 to 11 of 11 Posts